论文部分内容阅读
目的观察静脉滴注人免疫球蛋白治疗小儿重症肺炎的疗效。方法选取72例重症肺炎患儿并随机分为2组,对照组36例采用重症肺炎常规治疗,观察组36例患儿在对照组基础上加用人免疫球蛋白治疗,连续治疗3 d。观察比较2组患儿临床症状体征消失时间、临床疗效及住院时间。结果观察组患儿治疗有效率为91.67%,对照组为72.22%,观察组患儿治疗效果明显优于对照组(P<0.05)。结论对小儿重症肺炎患儿在采用常规治疗基础上加用人免疫球蛋白治疗,疗效显著。
Objective To observe the curative effect of intravenous infusion of human immunoglobulin on pediatric severe pneumonia. Methods Seventy-two children with severe pneumonia were selected and randomly divided into two groups. The control group received routine pneumonia treatment. In the observation group, 36 cases were treated with human immunoglobulin on the basis of the control group for 3 days. The clinical symptoms and signs disappeared, the clinical efficacy and hospital stay were observed and compared between the two groups. Results The effective rate of treatment group was 91.67% in observation group and 72.22% in control group. The treatment effect in observation group was better than that in control group (P <0.05). Conclusion Children with severe pneumonia in children with conventional treatment based on the addition of human immunoglobulin therapy, the effect was significant.